Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 435

1.

Biospecimen Utilization: A Critical Challenge in Global Bioresource/Biobanking Operations.

Bledsoe MJ, Grizzle WE.

Biopreserv Biobank. 2019 Jun;17(3):201-203. doi: 10.1089/bio.2019.29054.mjb. No abstract available.

PMID:
31188631
2.

Biological, Medical, and Other Tissue Variables Affecting Biospecimen Utilization.

Otali D, Al Diffalha S, Grizzle WE.

Biopreserv Biobank. 2019 Jun;17(3):258-263. doi: 10.1089/bio.2018.0094.

PMID:
31188629
3.

Biobank: What's in a Name?

Watson PH, Hewitt RE, Catchpoole DR, Grizzle WE.

Biopreserv Biobank. 2019 Jun;17(3):204-208. doi: 10.1089/bio.2019.29053.mjb. No abstract available.

PMID:
31188628
4.

The Utilization of Biospecimens: Impact of the Choice of Biobanking Model.

Grizzle WE, Bledsoe MJ, Al Diffalha S, Otali D, Sexton KC.

Biopreserv Biobank. 2019 Jun;17(3):230-242. doi: 10.1089/bio.2019.0008.

PMID:
31188627
5.

The Importance of Human Tissue Bioresources in Advancing Biomedical Research.

Al Diffalha S, Sexton KC, Watson PH, Grizzle WE.

Biopreserv Biobank. 2019 Jun;17(3):209-212. doi: 10.1089/bio.2019.0039.

PMID:
31188626
6.

Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future Mistakes.

Grizzle WE, Sexton KC.

Biopreserv Biobank. 2019 Jun;17(3):243-247. doi: 10.1089/bio.2018.0080. Epub 2018 Dec 1.

PMID:
30508389
7.

Lessons Learned During Three Decades of Operations of Two Prospective Bioresources.

Grizzle WE, Sexton KC, McGarvey D, Menchhofen ZV, LiVolsi V.

Biopreserv Biobank. 2018 Nov 20. doi: 10.1089/bio.2018.0073. [Epub ahead of print]

PMID:
30457879
8.

Nitrocellulose tissue prints: an innovative approach to preparing high quality DNA and RNA from prostate biopsies without compromising the cores for pathology diagnosis.

Gaston SM, Grizzle WE, Rais-Bahrami S, Kearney GP.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S514-S518. doi: 10.21037/tau.2018.09.01.

9.

A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.

Chakravarthi BVSK, Rodriguez Pena MDC, Agarwal S, Chandrashekar DS, Hodigere Balasubramanya SA, Jabboure FJ, Matoso A, Bivalacqua TJ, Rezaei K, Chaux A, Grizzle WE, Sonpavde G, Gordetsky J, Netto GJ, Varambally S.

Neoplasia. 2018 Sep;20(9):894-904. doi: 10.1016/j.neo.2018.07.006. Epub 2018 Aug 15.

10.

Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.

Samykutty A, Grizzle WE, Fouts BL, McNally MW, Chuong P, Thomas A, Chiba A, Otali D, Woloszynska A, Said N, Frederick PJ, Jasinski J, Liu J, McNally LR.

Biomaterials. 2018 Nov;182:114-126. doi: 10.1016/j.biomaterials.2018.08.001. Epub 2018 Aug 4.

PMID:
30118979
11.

Factors that drive the increasing use of FFPE tissue in basic and translational cancer research.

Gaffney EF, Riegman PH, Grizzle WE, Watson PH.

Biotech Histochem. 2018;93(5):373-386. doi: 10.1080/10520295.2018.1446101. Epub 2018 Aug 16. Review.

PMID:
30113239
12.

Reply to "Phase II prospective randomized trial of weight loss prior to radical prostatectomy".

Demark-Wahnefried W, Rais-Bahrami S, Desmond RA, Gordetsky JB, Azrad M, Frugé AD, Yang ES, Norian LA, Grizzle WE.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):293-294. doi: 10.1038/s41391-018-0038-9. Epub 2018 Apr 24. No abstract available.

13.

Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition.

Vaklavas C, Zinn KR, Samuel SL, Meng Z, Grizzle WE, Choi H, Blume SW.

Oncol Rep. 2018 Jun;39(6):2482-2498. doi: 10.3892/or.2018.6332. Epub 2018 Mar 23.

14.

Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.

Demark-Wahnefried W, Rais-Bahrami S, Desmond RA, Gordetsky JB, Hunter GR, Yang ES, Azrad M, Frugé AD, Tsuruta Y, Norian LA, Segal R, Grizzle WE.

Br J Cancer. 2017 Oct 24;117(9):1303-1313. doi: 10.1038/bjc.2017.303. Epub 2017 Sep 7.

15.

Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.

Vaklavas C, Blume SW, Grizzle WE.

Front Oncol. 2017 Jul 26;7:158. doi: 10.3389/fonc.2017.00158. eCollection 2017. Review.

16.

Epigenetic risk score improves prostate cancer risk assessment.

Van Neste L, Groskopf J, Grizzle WE, Adams GW, DeGuenther MS, Kolettis PN, Bryant JE, Kearney GP, Kearney MC, Van Criekinge W, Gaston SM.

Prostate. 2017 Sep;77(12):1259-1264. doi: 10.1002/pros.23385. Epub 2017 Aug 1.

PMID:
28762545
17.

Acidic pH-targeted chitosan capped mesoporous silica coated gold nanorods facilitate detection of pancreatic tumors via multispectral optoacoustic tomography.

Zeiderman MR, Morgan DE, Christein JD, Grizzle WE, McMasters KM, McNally LR.

ACS Biomater Sci Eng. 2016 Jul 11;2(7):1108-1120. doi: 10.1021/acsbiomaterials.6b00111. Epub 2016 Jun 6.

18.

Erratum to: Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.

Demark-Wahnefried W, Nix JW, Hunter GR, Rais-Bahrami S, Desmond RA, Chacko B, Morrow CD, Azrad M, Frugé AD, Tsuruta Y, Ptacek T, Tully SA, Segal R, Grizzle WE.

BMC Cancer. 2017 Jan 23;17(1):71. doi: 10.1186/s12885-016-3025-3. No abstract available.

19.

Genomic regulation of invasion by STAT3 in triple negative breast cancer.

McDaniel JM, Varley KE, Gertz J, Savic DS, Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby MK, Newberry KM, Partridge EC, Jones AL, Boone B, Levy SE, Oliver PG, Sexton KC, Grizzle WE, Forero A, Buchsbaum DJ, Cooper SJ, Myers RM.

Oncotarget. 2017 Jan 31;8(5):8226-8238. doi: 10.18632/oncotarget.14153.

20.

Noninvasive Imaging of Colitis Using Multispectral Optoacoustic Tomography.

Bhutiani N, Grizzle WE, Galandiuk S, Otali D, Dryden GW, Egilmez NK, McNally LR.

J Nucl Med. 2017 Jun;58(6):1009-1012. doi: 10.2967/jnumed.116.184705. Epub 2016 Dec 1.

21.

Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations.

Seijo E, Lima D, Iriabho E, Almeida J, Monico J, Echeverri M, Gutierrez S, Flores I, Lee JH, Fisher K, Grizzle WE, Sica GL, Butler C, Hicks C, Meade CD, Sodeke SO, Moroz K, Coppola D, Munoz-Antonia T.

Cancer Control. 2016 Oct;23(4):383-389.

22.

The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.

Ottman R, Levy J, Grizzle WE, Chakrabarti R.

Oncotarget. 2016 Nov 8;7(45):73739-73753. doi: 10.18632/oncotarget.12061.

23.

Exploring effects of presurgical weight loss among women with stage 0-II breast cancer: protocol for a randomised controlled feasibility trial.

Tsuruta Y, Rogers LQ, Krontiras H, Grizzle WE, Frugé AD, Oster RA, Umphrey HR, Jones LW, Azrad M, Demark-Wahnefried W.

BMJ Open. 2016 Sep 15;6(9):e012320. doi: 10.1136/bmjopen-2016-012320.

24.

Effects of Cold Ischemia on Gene Expression: A Review and Commentary.

Grizzle WE, Otali D, Sexton KC, Atherton DS.

Biopreserv Biobank. 2016 Dec;14(6):548-558. Epub 2016 Aug 23. Review.

25.

IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells.

Vaklavas C, Grizzle WE, Choi H, Meng Z, Zinn KR, Shrestha K, Blume SW.

Tumour Biol. 2016 Oct;37(10):13247-13264. Epub 2016 Jul 26.

26.

RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.

Kirby MK, Ramaker RC, Gertz J, Davis NS, Johnston BE, Oliver PG, Sexton KC, Greeno EW, Christein JD, Heslin MJ, Posey JA, Grizzle WE, Vickers SM, Buchsbaum DJ, Cooper SJ, Myers RM.

Mol Oncol. 2016 Oct;10(8):1169-82. doi: 10.1016/j.molonc.2016.05.004. Epub 2016 May 26.

27.

A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines.

Zhang J, Riby JE, Conde L, Grizzle WE, Cui X, Skibola CF.

BMC Complement Altern Med. 2016 May 28;16:151. doi: 10.1186/s12906-016-1129-6.

28.

The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.

Schultz MJ, Holdbrooks AT, Chakraborty A, Grizzle WE, Landen CN, Buchsbaum DJ, Conner MG, Arend RC, Yoon KJ, Klug CA, Bullard DC, Kesterson RA, Oliver PG, O'Connor AK, Yoder BK, Bellis SL.

Cancer Res. 2016 Jul 1;76(13):3978-88. doi: 10.1158/0008-5472.CAN-15-2834. Epub 2016 May 23.

29.

Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology.

McNally LR, Mezera M, Morgan DE, Frederick PJ, Yang ES, Eltoum IE, Grizzle WE.

Clin Cancer Res. 2016 Jul 15;22(14):3432-9. doi: 10.1158/1078-0432.CCR-16-0573. Epub 2016 May 20. Review.

30.

A standard tissue as a control for histochemical and immunohistochemical staining.

Otali D, Fredenburgh J, Oelschlager DK, Grizzle WE.

Biotech Histochem. 2016 Jul;91(5):309-26. doi: 10.1080/10520295.2016.1179342. Epub 2016 May 5.

31.

Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes.

Forero A, Li Y, Chen D, Grizzle WE, Updike KL, Merz ND, Downs-Kelly E, Burwell TC, Vaklavas C, Buchsbaum DJ, Myers RM, LoBuglio AF, Varley KE.

Cancer Immunol Res. 2016 May;4(5):390-9. doi: 10.1158/2326-6066.CIR-15-0243. Epub 2016 Mar 15.

32.

Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy.

Birket SE, Chu KK, Houser GH, Liu L, Fernandez CM, Solomon GM, Lin V, Shastry S, Mazur M, Sloane PA, Hanes J, Grizzle WE, Sorscher EJ, Tearney GJ, Rowe SM.

Am J Physiol Lung Cell Mol Physiol. 2016 May 15;310(10):L928-39. doi: 10.1152/ajplung.00395.2015. Epub 2016 Mar 11.

33.

Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.

Demark-Wahnefried W, Nix JW, Hunter GR, Rais-Bahrami S, Desmond RA, Chacko B, Morrow CD, Azrad M, Frugé AD, Tsuruta Y, Ptacek T, Tully SA, Segal R, Grizzle WE.

BMC Cancer. 2016 Feb 5;16:61. doi: 10.1186/s12885-016-2075-x. Erratum in: BMC Cancer. 2017 Jan 23;17 (1):71.

34.

Factors Affecting the Use of Human Tissues in Biomedical Research: Implications in the Design and Operation of a Biorepository.

Atherton DS, Sexton KC, Otali D, Bell WC, Grizzle WE.

Methods Mol Biol. 2016;1381:1-38. doi: 10.1007/978-1-4939-3204-7_1. Review.

PMID:
26667452
35.

Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.

Boone JD, Arend RC, Johnston BE, Cooper SJ, Gilchrist SA, Oelschlager DK, Grizzle WE, McGwin G Jr, Gangrade A, Straughn JM Jr, Buchsbaum DJ.

Lab Invest. 2016 Feb;96(2):249-59. doi: 10.1038/labinvest.2015.150. Epub 2015 Dec 14.

36.

Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography.

Yin W, Kimbrough CW, Gomez-Gutierrez JG, Burns CT, Chuong P, Grizzle WE, McNally LR.

J Nanobiotechnology. 2015 Dec 1;13:90. doi: 10.1186/s12951-015-0139-8.

37.

Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer.

Ludwig MR, Kojima K, Bowersock GJ, Chen D, Jhala NC, Buchsbaum DJ, Grizzle WE, Klug CA, Mobley JA.

Proteomics. 2016 Feb;16(3):516-31. doi: 10.1002/pmic.201500133. Epub 2016 Jan 18.

PMID:
26572242
38.

Missed Opportunities and Lost Lives: Consequences of Some Proposed Changes to Regulations on Research with Human Tissues--Letter.

Grizzle WE.

Clin Cancer Res. 2015 Dec 1;21(23):5404-5. doi: 10.1158/1078-0432.CCR-15-2513. Epub 2015 Oct 19. No abstract available.

39.

High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.

Anderson JC, Willey CD, Mehta A, Welaya K, Chen D, Duarte CW, Ghatalia P, Arafat W, Madan A, Sudarshan S, Naik G, Grizzle WE, Choueiri TK, Sonpavde G.

PLoS One. 2015 Sep 25;10(9):e0139267. doi: 10.1371/journal.pone.0139267. eCollection 2015.

40.

The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?

Li R, Zhang K, Penedo TL, Kragel CP, Grizzle WE, Hameed O, Siegal GP, Wei S.

Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):42-50. doi: 10.1097/PAI.0000000000000151.

PMID:
26200837
41.

Small molecule inhibitors of IRES-mediated translation.

Vaklavas C, Meng Z, Choi H, Grizzle WE, Zinn KR, Blume SW.

Cancer Biol Ther. 2015;16(10):1471-85. doi: 10.1080/15384047.2015.1071729. Epub 2015 Jul 15.

42.

Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.

Kimbrough CW, Khanal A, Zeiderman M, Khanal BR, Burton NC, McMasters KM, Vickers SM, Grizzle WE, McNally LR.

Clin Cancer Res. 2015 Oct 15;21(20):4576-85. doi: 10.1158/1078-0432.CCR-15-0314. Epub 2015 Jun 29.

43.

Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.

Putcha BD, Jia X, Katkoori VR, Salih C, Shanmugam C, Jadhav T, Bovell LC, Behring MP, Callens T, Messiaen L, Bae S, Grizzle WE, Singh KP, Manne U.

PLoS One. 2015 Jun 12;10(6):e0129216. doi: 10.1371/journal.pone.0129216. eCollection 2015.

44.

Quality management of biorepositories.

Grizzle WE, Gunter EW, Sexton KC, Bell WC.

Biopreserv Biobank. 2015 Jun;13(3):183-94. doi: 10.1089/bio.2014.0105.

45.

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.

Che P, Yang Y, Han X, Hu M, Sellers JC, Londono-Joshi AI, Cai GQ, Buchsbaum DJ, Christein JD, Tang Q, Chen D, Li Q, Grizzle WE, Lu YY, Ding Q.

Sci Rep. 2015 Feb 13;5:8453. doi: 10.1038/srep08453.

46.

A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression.

Green HN, Crockett SD, Martyshkin DV, Singh KP, Grizzle WE, Rosenthal EL, Mirov SB.

Int J Nanomedicine. 2014 Nov 5;9:5093-102. doi: 10.2147/IJN.S60648. eCollection 2014.

47.

A functional anatomic defect of the cystic fibrosis airway.

Birket SE, Chu KK, Liu L, Houser GH, Diephuis BJ, Wilsterman EJ, Dierksen G, Mazur M, Shastry S, Li Y, Watson JD, Smith AT, Schuster BS, Hanes J, Grizzle WE, Sorscher EJ, Tearney GJ, Rowe SM.

Am J Respir Crit Care Med. 2014 Aug 15;190(4):421-32. doi: 10.1164/rccm.201404-0670OC.

48.

Erythropoietin upregulation in pulmonary arterial hypertension.

Karamanian VA, Harhay M, Grant GR, Palevsky HI, Grizzle WE, Zamanian RT, Ihida-Stansbury K, Taichman DB, Kawut SM, Jones PL.

Pulm Circ. 2014 Jun;4(2):269-79. doi: 10.1086/675990.

49.

IL-23 promotes TCR-mediated negative selection of thymocytes through the upregulation of IL-23 receptor and RORγt.

Li H, Hsu HC, Wu Q, Yang P, Li J, Luo B, Oukka M, Steele CH 3rd, Cua DJ, Grizzle WE, Mountz JD.

Nat Commun. 2014 Jul 8;5:4259. doi: 10.1038/ncomms5259.

50.

Pazopanib combined with radiation: in vivo model of interaction.

Meredith RF, Raisch KP, Bonner JA, Buchsbaum DJ, Grizzle WE, Li Y, Spencer SA.

Cancer Biother Radiopharm. 2014 Aug;29(6):247-50. doi: 10.1089/cbr.2013.1583. Epub 2014 Jun 19.

PMID:
24945464

Supplemental Content

Loading ...
Support Center